Europe Ophthalmology Market - Industry Trends and Forecast to 2032

Personnalisez votre rapport Personnalisez votre rapport Acheter maintenantAcheter maintenant Exemple de rapport gratuitExemple de rapport gratuit
Maison Medical Devices Europe Ophthalmology Market
Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Exemple de rapport gratuitExemple de rapport gratuit Renseignez-vous avant d'acheterRenseignez-vous avant Acheter maintenantAcheter maintenant

Europe Ophthalmology Market - Industry Trends and Forecast to 2032

  • Medical Devices
  • Publish Reports
  • Nov 2024
  • Europe
  • 350 Pages
  • Nombre de tableaux : 478
  • Nombre de figures : 38
Buy Now Acheter maintenant Request for Sample Télécharger un échantillon PDF gratuit
Nucleus Nucleus

Europe Ophthalmology Market

Taille du marché en milliards USD

TCAC :  % Diagram

Chart Image USD 22.23 Billion USD 38.00 Billion 2024 2032
Diagram Période de prévision
 2025 –2032
Diagram Taille du marché (année de référence)
 USD 22.23 Billion
Diagram Taille du marché (année de prévision)
 USD 38.00 Billion
Diagram TCAC
 %
DiagramPrincipaux acteurs du marché
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5 < /li>
Demande de déverrouillage

Europe Ophthalmology Market Segmentation, By Products (Device, Drugs, and Others), Diseases (Cataract, Refractive Disorders, Glaucoma, Age-Related Macular Degeneration, Inflammatory Diseases, and Others), Comprehensive Eye Examination (Refraction, Visual Acuity Test, Intraocular Pressure, Anterior Segment and Pupillary Examination, Visual Fields Test, Color Vision Test, and Others), End User (Clinics, Hospitals, Home Healthcare, and Others), Distribution Channel (Retail Sales, Direct Tender, and Others) - Industry Trends and Forecast to 2032

Europe Ophthalmology Market

Europe Ophthalmology Market Analysis

The Europe ophthalmology market has evolved significantly over the centuries, beginning with ancient treatments for eye conditions in Egypt and Greece. The field began to take shape in the 17th and 18th centuries, with the development of more advanced surgical techniques and tools. In the 19th century, innovations like the ophthalmoscope transformed diagnostic capabilities. The 20th century saw breakthroughs such as cataract surgery and the invention of intraocular lenses, along with the advent of LASIK surgery in the 1990s. The 21st century brought continued growth driven by an aging population, technological advancements, and the development of specialized diagnostic and surgical devices, including optical coherence tomography (OCT) and retinal imaging systems. Recent trends focus on the increasing use of artificial intelligence, telemedicine, and biologic therapies, such as gene therapy and stem cell treatments, further shaping the market's growth. Today, the ophthalmology market continues to expand due to rising eye disease prevalence, new technologies, and evolving treatment options.

Europe Ophthalmology Market Size

The Europe ophthalmology market is expected to reach USD 38.00 billion by 2032 from USD 22.23 billion in 2024, growing at a CAGR of 7.0% in the forecast period of 2025 to 2032.  

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.

 Europe Ophthalmology Market Trends

“The growing adoption of telemedicine and AI-powered diagnostic tools”

The Europe ophthalmology market is the growing adoption of telemedicine and AI-powered diagnostic tools. These innovations are transforming the way eye care is delivered by enabling remote consultations and screenings, which increases accessibility, especially in underserved and rural areas. AI technologies, including machine learning algorithms, are being used to analyze retinal images, detect early signs of conditions like diabetic retinopathy, glaucoma, and macular degeneration, and provide faster, more accurate diagnoses. Telemedicine platforms allow patients to connect with ophthalmologists for follow-up consultations, reducing the need for in-person visits and making eye care more convenient and efficient. This trend is not only improving patient access to timely treatments but also enhancing the overall efficiency of healthcare systems, making it a key driver of market growth in the ophthalmology sector. As a result, the integration of these technologies is expected to continue expanding, particularly in emerging markets, where healthcare infrastructure is still developing.

Report Scope and Europe Ophthalmology Market Segmentation    

Attributes

Europe Ophthalmology Market Insights

Segments Covered

By Products: Device, Drugs, and Others

By Diseases: Cataract, Refractive Disorders, Glaucoma, Age-Related Macular Degeneration, Inflammatory Diseases, and Others

By Comprehensive Eye Examination: Refraction, Visual Acuity Test, Intraocular Pressure, Anterior Segment and Pupillary Examination, Visual Fields Test, Color Vision Test, and Others

By End User: Clinics, Hospitals, Home Healthcare, and Others

By Distribution Channel: Retail Sales, Direct Tender, and Others

Region Covered

Germany, France, U.K., Italy, Spain, Switzerland, Russia, Belgium, Netherlands, Turkey, and Rest of Europe

Key Market Players

Alcon (Switzerland), Bausch + Lomb (Canada), Carl Zeiss Meditec (Germany), Hoya Corporation (Japan), Johnson & Johnson Services, Inc. (U.S.), Essilor International (France), Topcon Corporation(Japan), Glaukos Corporation (U.S.), Haag-Streit Group (Switzerland), Nidek Co., Ltd (U.S.), Staar Surgical (California), Ziemer Ophthalmic Systems Ag (Switzerland), Cooper Companies (U.S.), Lumenis Be Ltd. (Israel), Reichert Inc. (New York), Bayer Ag (Germany), Novartis Ag (Switzerland), Abbvie Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Dompé (Italy), Santen Pharmaceutical Co. (Japan), Ltd among others

Market Opportunities

  • Rise in the aging population
  • Rise in online retail and e-health platforms
  • Enhanced patient education

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.

Europe Ophthalmology Market Definition

Ophthalmology is a branch of medicine and surgery that focuses on the diagnosis, treatment, and prevention of eye disorders and diseases. It includes medical and surgical care for conditions affecting the eyes and visual systems, such as cataracts, glaucoma, macular degeneration, and diabetic retinopathy.

Europe Ophthalmology Market Definition Dynamics

Drivers  

Drivers  

  • Increasing Prevalence of Eye Diseases

The increasing prevalence of eye conditions, such as cataracts, macular degeneration, and diabetic retinopathy, is a significant driver of the Europe ophthalmology market. As the Europe population ages, the incidence of these conditions is rise. Cataracts, which lead to blurred vision and blindness, demand an expanding market for surgeries and corrective treatments. Similarly, macular degeneration and diabetic retinopathy are contributing to the need for advanced diagnostic tools and specialized therapies. The growing number of affected individuals ensures sustained demand for eye care services, including surgeries, medications, and innovative diagnostic technologies. This surge in eye diseases directly drives market expansion, as healthcare providers and manufacturers strive to meet the growing need for effective treatments and solutions.

For instance,

  • In July 2022, according to the article published by NCBI, The prevalence of blindness rises with age, increasing from 0.45% in those aged 50-59 to 11.62% in individuals 80 and older. Females (2.31%) and rural residents (2.14%) experience higher rates. Visual impairment also affects 26.68% of participants, showing similar trends. This growing burden of eye diseases, particularly among the elderly, drives demand for ophthalmic treatments and technologies, boosting the ophthalmology market
  • In August 2023, according to the article published by WHO, Europe, over 2.2 billion people suffer from vision impairment, with nearly 1 billion cases being preventable or untreated. This growing prevalence of vision issues highlights the increasing demand for eye care services, treatments, and corrective solutions. As more people seek medical attention for preventable or unresolved conditions, the rising burden of eye diseases acts as a significant driver for the ophthalmology market

The rising prevalence of age-related eye conditions like cataracts, macular degeneration, and diabetic retinopathy is fueling the Europe ophthalmology market. As the population ages, these diseases become more common, increasing the demand for treatments, surgeries, and diagnostic tools. The need for advanced technologies and therapies grows as more people require care. This surge in eye conditions drives market growth, as healthcare providers and manufacturers aim to meet the rising demand for effective solutions.

  • Focus on Preventative Eye Care  

There is a growing emphasis on preventative eye care and early detection of vision-related issues, which is playing a significant role in driving the Europe ophthalmology market. As awareness about the importance of eye health increases, more people are seeking routine eye checkups to detect conditions like glaucoma, diabetic retinopathy, and cataracts in their early stages. Early diagnosis allows for timely interventions, reducing the risk of vision loss and improving overall eye health. This proactive approach is not only improving patient outcomes but also fueling demand for ophthalmic services, diagnostic tools, and corrective treatments. The growing focus on preventative care is leading to a surge in investments in eye care technologies, ophthalmic devices, and services, thereby contributing to the market's expansion. This trend strongly acts as a driver for growth in the ophthalmology sector.

For instance,

  • In October 2022, according to the article published by National Eye Institute, National Eye Health Education Program(NEHEP) collaborates with health professionals to promote awareness on early detection, treatment of eye diseases, and the benefits of vision rehabilitation. It also targets populations at high risk of eye disease and vision loss. This focus on preventative care encourages people to seek timely eye check-ups and treatments, driving demand for ophthalmic services, diagnostic tools, and products, thereby fueling the ophthalmology market
  • In October 2024, according to the article published by Directorate General of Health Services, The National Programme for Control of Blindness and Visual Impairment (NPCB&VI) aims to reduce blindness prevalence by identifying and treating curable blindness at all healthcare levels. By focusing on early detection and addressing avoidable blindness, the program highlights the importance of preventative care. This initiative drives demand for eye care services, diagnostic tools, and treatments, contributing significantly to the growth of the Europe ophthalmology market

The increasing focus on preventative eye care and early detection is significantly driving the Europe ophthalmology market. As awareness of eye health rises, more individuals are opting for routine eye exams to identify conditions like glaucoma and cataracts early. Early detection allows for effective treatments that prevent further vision loss. This proactive approach is driving demand for diagnostic tools, ophthalmic services, and corrective treatments. The growing importance of preventative care is prompting investment in advanced eye care technologies, thus contributing to the overall growth of the ophthalmology market and ensuring its continued expansion.

Opportunities

  • Rise in the Aging Population

The rise in the aging population presents a significant opportunity for the Europe ophthalmology market, as older individuals are more susceptible to various eye disorders and diseases. Conditions such as cataracts, age-related macular degeneration (AMD), diabetic retinopathy, and glaucoma are prevalent among the elderly, creating a substantial demand for ophthalmic care and treatments. As a result, healthcare systems and ophthalmic providers are poised to expand their services, enhance diagnostic and therapeutic options, and cater to the unique needs of this demographic. This growing patient base necessitates an array of solutions, from surgical interventions and advanced drug therapies to vision correction products, ensuring a steady and increasing demand for ophthalmic procedures and products.

For instance,

  • In March 2023, according to an article published in the National Library of Medicine, Cataract is a leading cause of visual impairment in old age. Lens opacification is notoriously associated with several geriatric conditions, including frailty, fall risk, depression and cognitive impairment. Moreover, according to the same source, in 2020, the leading worldwide causes of blindness in patients aged 50 years and older were cataract, followed by glaucoma, under-corrected refractive error, age-related macular degeneration, and diabetic retinopathy
  • In August 2022, according to an article published in the American Academy of Ophthalmology, AMD is a common eye disease, usually found in adults over the age of 50. Moreover, it is stated that Half of Americans over the age of 75 develop cataracts

Moreover, addressing the eye health needs of the aging population can stimulate further investments in research and development within the ophthalmology sector. Pharmaceutical companies and medical device manufacturers are focus on creating innovative solutions tailored specifically for age-related conditions, potentially leading to breakthroughs in treatment protocols and patient care. The integration of new technologies, such as tele ophthalmology and advanced imaging techniques, facilitate better management of eye health in older adults, making it easier to monitor and treat conditions remotely. Overall, the aging population amplifies the need for existing ophthalmic services and presents a fertile ground for innovation and growth within the Europe ophthalmology market.

  • Rise in Online Retail and E-Health Platforms

The rise of online retail and e-health platforms offers a significant opportunity for the Europe ophthalmology market by providing consumers with easier access to a wide array of eye care products and services. With the increasing adoption of e-commerce, patients can conveniently purchase items such as prescription glasses, contact lenses, and over-the-counter eye care products from the comfort of their homes. This trend is especially appealing to younger, tech-savvy consumers and those in remote areas with limited access to traditional optical stores. The ability to compare prices, read reviews, and access a wider range of products online enhances customer satisfaction and encourages usage, thereby driving growth in the ophthalmic product segment.

For instance,

  • In September 2023, according to a news article from The Times of India, the 'pink eye' outbreak led to a surge in sales of ophthalmology medicine. Sales jumped nearly 30% year-on-year for the second month in a row in August - outgrowing the overall market by almost five times. The rise reflects the massive incidence of conjunctivitis and eye-complications in the last few months across the country
  • In April 2020, according to an article, ‘Patient views about online purchasing of eyewear’, online purchasing of contact lenses is on the rise: 10%–20% of contact lens wearers in Australia, U.S. and the UK have considered or researched the possibility of Internet purchasing

In addition to retail opportunities, e-health platforms facilitate telehealth services that allow patients to consult with eye care professionals remotely. Virtual consultations for routine eye examinations, follow-ups, and triaging for more serious conditions can significantly improve access to care, particularly for older adults or individuals with mobility challenges. These platforms enhance patient engagement and adherence to eye health recommendations and allow ophthalmologists to reach a broader patient base without the constraints of geographic boundaries. Furthermore, the integration of digital health tools, such as mobile apps for monitoring eye health or managing chronic conditions, can create a seamless patient experience and foster proactive eye care, further propelling growth in the ophthalmology market.

Restraints/Challenges

  • Side Effects and Complications Related to Eye Surgeries

Despite the significant advancements in ophthalmology treatments, certain ophthalmic procedures, particularly surgical interventions, carry risks of side effects and complications such as infection, scarring, or vision impairment. These potential risks can deter patients from undergoing specific therapies, especially those that involve invasive procedures. The fear of adverse outcomes, such as reduced vision or prolonged recovery times, can lead to hesitancy in seeking treatment, limiting the overall adoption of certain therapies. Additionally, complications arising from surgeries might require additional treatments, further raising healthcare costs and impacting patient trust in advanced treatments. This reluctance to undergo treatments due to the potential for negative side effects restricts the overall growth of the ophthalmology market by slowing down the adoption of new technologies and therapies. 

For instance,

  • In October 2024, according to the article published by Harvard Health, Modern eye surgeries, while effective in treating conditions like cataracts and glaucoma, often lead to complications such as dry eye disease, characterized by a burning, gritty, or itchy sensation. This side effect can be uncomfortable and discouraging for patients, leading some to hesitate or avoid eye surgeries. As a result, complications from treatments act as a restraint on the growth of the ophthalmology market
  • In July 2021, according to the article published by Medical News Today, Up to 95% of individuals who undergo laser eye surgery may experience dry eyes, while 20% report visual disturbances like glare or halos. Additionally, 1 in 50 people may suffer from blurry vision or “sands of Sahara” syndrome. These side effects can discourage patients from opting for surgery, limiting the adoption of laser procedures and acting as a restraint on the ophthalmology market’s growth

Despite advancements in ophthalmology, some surgical treatments carry risks such as infection, scarring, or vision impairment. These complications can discourage patients from opting for certain therapies, particularly invasive procedures. The fear of adverse outcomes and additional treatment costs can hinder patient willingness to seek care, slowing the adoption of new treatments. This reluctance limits the growth of the Europe ophthalmology market.

  • Limited Access to specialized Ophthalmic Care in Rural Areas

Despite advancements in healthcare infrastructure, access to specialized ophthalmic care remains limited in rural and remote areas, significantly hindering the growth potential of the ophthalmology market in these regions. Many rural populations still face challenges such as a lack of trained eye care professionals, inadequate facilities, and limited access to advanced diagnostic and treatment technologies. As a result, individuals in these areas often struggle to receive timely diagnosis and treatment for eye conditions, leading to a higher incidence of preventable blindness and vision impairment. The limited availability of specialized care restricts market expansion by reducing the adoption of advanced eye care services and products. This barrier to access continues to act as a major restraint on the Europe ophthalmology market’s overall growth.

For Instance,

  • In February 2023, according to the article published by NCBI, India's large rural population faces significant unmet eye care needs, with most facilities and professionals concentrated in urban and semi-urban areas. The disparity in access to eye care between rural and urban regions remains a challenge, limiting treatment availability. This unequal distribution of healthcare resources restricts the growth of the Europe ophthalmology market by preventing widespread access to essential services in rural areas
  • In March 2024, according to the article published by Research Gate, The lack of connectivity and trained staff in remote areas hampers access to continuous eye care, even after successful eye camps. Patients in these areas struggle to receive follow-up care or advanced treatments due to the absence of proper infrastructure. This gap in healthcare delivery limits the reach and effectiveness of eye care programs, acting as a restraint on the Europe ophthalmology market's growth

Access to specialized eye care is still limited in rural areas, despite healthcare improvements. The shortage of eye care professionals, advanced technology, and facilities prevents timely treatment and diagnosis, leading to higher rates of avoidable blindness. This limited access hampers the growth of the Europe ophthalmology market by restricting adoption of advanced treatments and services in these regions.

Europe Ophthalmology Market Scope

Le marché est segmenté en fonction des produits, des maladies, de l'examen oculaire complet, de l'utilisateur final et du canal de distribution. La croissance parmi ces segments vous aidera à analyser les segments de croissance faibles dans les industries et à fournir aux utilisateurs un aperçu précieux du marché et des informations sur le marché pour les aider à prendre des décisions stratégiques pour identifier les principales applications du marché.

Par produits

  • Appareil
    • Dispositif chirurgical
      • Dispositifs chirurgicaux pour la cataracte
      • Dispositifs viscoélastiques ophtalmiques
        • Dispositifs de phacoémulsification
        • Lasers pour la chirurgie de la cataracte
        • Injecteurs IOL
      • Dispositifs chirurgicaux vitréo-rétiniens
        • Appareils de vitrectomie
        • Packs vitréo-rétiniens
        • Lasers de photocoagulation
        • Sondes de vitrectomie
        • Dispositifs d'éclairage
      • Dispositifs de chirurgie réfractive
        • Lasers femtosecondes
        • Lasers à excimère
        • Autres lasers chirurgicaux réfractifs
      • Dispositifs chirurgicaux pour le traitement du glaucome
        • Dispositifs de drainage du glaucome
        • Dispositifs de chirurgie micro-invasive du glaucome
        • Systèmes laser pour le traitement du glaucome
    • Appareil de diagnostic
      • Scanners de tomographie par cohérence optique (OCT)
      • Autoréfracteurs et kératomètres
      • Tonomètres
      • Réfracteurs
      • Rétinoscopes
      • Ophtalmoscopes
      • Lampes à fente
      • Périmètres/Analyseurs de champ visuel
      • Systèmes de topographie cornéenne
      • Caméras de fond d'œil
      • Systèmes d'imagerie ophtalmique par ultrasons
        • A- Système d'imagerie par balayage
        • Système d'imagerie B-Scan
        • Pachymètres
        • Biomicroscopes à ultrasons
      • Frontofocomètres
      • Aberromètres de front d'onde
      • Systèmes de biométrie optique
      • Microscopes spéculaires
      • Projecteurs de cartes
    • Accessoires pour chirurgie ophtalmique
      • Instruments et kits chirurgicaux
      • Pince ophtalmique
      • Spatule Ophtalmique
      • Embouts et poignées ophtalmiques
      • Canules ophtalmiques
      • Ciseaux Ophtalmiques
      • Autres accessoires chirurgicaux
    • Microscopes ophtalmiques
  • Médicaments, sous-produits
    • Médicaments anti-VEGF
      • Ranibizumab
      • Bévacizumab
    • Médicaments contre les troubles rétiniens
    • Médicaments contre le glaucome
      • Analogues de la prostaglandine
        • Latanoprost
        • Bimatoprost
        • Travoprost
        • Tafluprost
        • Latanoprostène
      • Antagonistes bêta-adrénergiques
        • Maléate de timolal
        • Bétaxolol
      • Agonistes alpha-adrénergiques
        • Épinéphrine
        • Dépivéprine
      • Miotiques
        • Pilocarpine
        • Ésérine
    • Médicaments contre la sécheresse oculaire
    • Médicaments anti-inflammatoires
      • Médicaments anti-inflammatoires stéroïdiens
      • Médicaments anti-inflammatoires non stéroïdiens
    • Médicaments contre la conjonctivite allergique
    • Autres
  • Médicaments, par type de médicament
    • De marque
    • Générique
  • Médicaments, par ordonnance
    • Ordonnance
    • Sur le comptoir
  • Médicaments, par voie d'administration
    • Topique
      • Gouttes pour les yeux
      • Solution pour les yeux
      • Crèmes et pommades
      • Gel
      • Autres
    • Oculaire local
      • Intravitréen
      • Sous-conjonctival
      • Rétrobulbaire
      • Intracaméral
    • Injectables
      • Intramusculaire
      • Intraveineux
      • Autres
    • Oral
      • Comprimé
      • Gélules
      • Autres
    • Autres
  • Autres
    • Produits de soins de la vue
      • Lunettes
      • Lentilles de contact
        • Lentilles de contact souples
        • Lentilles de contact hybrides
        • Lentilles rigides perméables au gaz
    • Autres

Par maladies

  • Cataracte
  • Troubles de la réfraction
  • Glaucome
  • Dégénérescence maculaire liée à l'âge
  • Maladies inflammatoires
  • Autres

Par un examen complet de la vue

  • Réfraction
    • Réfractomètres automatiques
    • Jeu de lentilles d'essai
    • Médicaments cycloplégiques
    • Cadre d'essai
    • Rétinoscope auto-éclairé/miroir
    • Cylindre croisé Jackson
  • Test d'acuité visuelle
    • Tableau de Snellen
    • Cartes de vision de près
  • Pression intraoculaire
    • Tonomètres (Goldmann, Tono-Pen, Perkins, Shiotz)
    • Autres
  • Examen du segment antérieur et de la pupille
    • Biomicroscope à lampe à fente
    • Lampe torche
  • Test des champs visuels
    • Analyseur de champ visuel Humphrey à seuil complet Central 30-2
    • Périmètre de doublage de fréquence
    • Périmètre cinétique de Goldmann
  • Test de vision des couleurs
  • Autres

Par utilisateur final

  • Cliniques
  • Hôpitaux
  • Soins à domicile
  • Autres

Par canal de distribution

  • Ventes au détail
    • Commerces de détail
    • Pharmacie de l'hôpital
    • Pharmacie en ligne
  • Appel d'offres direct
  • Autres

Analyse régionale du marché de l'ophtalmologie en Europe

Le marché est segmenté en fonction des produits, des maladies, de l’examen oculaire complet, de l’utilisateur final et du canal de distribution.

Les pays couverts par ce marché sont l’Allemagne, la France, le Royaume-Uni, l’Italie, l’Espagne, la Suisse, la Russie, la Belgique, les Pays-Bas, la Turquie et le reste de l’Europe.

L'Allemagne devrait dominer le marché en raison de ses infrastructures de santé avancées, de ses dépenses de santé élevées et d'une population vieillissante avec une prévalence croissante des maladies oculaires. En outre, des investissements importants dans la recherche, le développement et l'adoption de technologies de pointe favorisent le leadership du marché dans la région.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces du porteur, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques européennes et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et des routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.

Part de marché de l'ophtalmologie en Europe

Le paysage concurrentiel du marché fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence en Europe, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises par rapport au marché.

Les leaders du marché européen de l'ophtalmologie opérant sur le marché sont :

  • Alcon (Suisse)
  • Bausch + Lomb (Canada)
  • Carl Zeiss Meditec (Allemagne)
  • Hoya Corporation (Japon)
  • Johnson & Johnson Services, Inc. (États-Unis)
  • Essilor International (France)
  • Topcon Corporation (Japon)
  • Glaukos Corporation (États-Unis)
  • Groupe Haag-Streit (Suisse)
  • Nidek Co., Ltd (États-Unis)
  • Staar Surgical (Californie)
  • Ziemer Ophthalmic Systems Ag (Suisse)
  • Cooper Companies (États-Unis)
  • Lumenis Be Ltd. (Israël)
  • Reichert Inc. (New York)
  • Bayer AG (Allemagne)
  • Novartis AG (Suisse)
  • Abbvie Inc. (États-Unis)
  • F. Hoffmann-La Roche SA (Suisse)
  • Dompé (Italie)
  • Santen Pharmaceutical Co. (Japon)

Les derniers développements sur le marché européen de l'ophtalmologie

  • In October 2024, At the AAO 2024 meeting, Alcon showcased its innovations, including the Voyager DSLT for glaucoma treatment, UNIFEYE and UNIPEXY handheld gas delivery systems, and pivotal data for AR-15512, a dry eye treatment. These advancements aimed to improve outcomes and surgical efficiency
  • In September 2024, EssilorLuxottica and Meta have extended their partnership, entering a long-term agreement to develop multi-generational smart eyewear products. Building on the success of Ray-Ban Meta glasses, the companies aim to shape the future of wearable technology together
  • In OCTOBER 2024, Bausch + Lomb presented new scientific data and educational events at the 2024 AAO meeting in Chicago. Highlights included studies on the enVista Envy IOL, TENEO Excimer Laser, VYZULTA, and presentations on Blink Nutritears, MIEBO, and Xiidra
  • In April 2024, AbbVie has completed its acquisition of Cerevel Therapeutics, enhancing its neuroscience portfolio. The acquisition includes Cerevel’s promising clinical-stage assets like Emraclidine for schizophrenia and Tavapadon for Parkinson's disease, strengthening AbbVie’s position in neurology and psychiatry
  • In September, 2023, Novartis completed the divestment of its 'front of eye' ophthalmology assets to Bausch + Lomb for up to USD 2.5 billion, including USD 1.75 billion in upfront cash and potential milestone payments. The deal included Xiidra®, SAF312, AcuStream, and OJL332. Novartis advanced its strategy to focus on prioritized therapeutic areas for future growth

SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

Sample Image Cliquez sur l'image pour l'agrandir
  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE OPHTHALMOLOGY MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 PRODUCT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

5 EUROPE OPHTHALMOLOGY MARKET : REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PREVALENCE OF EYE DISEASES

6.1.2 FOCUS ON PREVENTATIVE EYE CARE

6.1.3 GOVERNMENT EYECARE INITIATIVES

6.1.4 INNOVATIONS IN OPHTHALMIC SURGICAL TECHNIQUES

6.2 RESTRAINTS

6.2.1 SIDE EFFECTS AND COMPLICATIONS RELATED TO EYE SURGERIES

6.2.2 LIMITED ACCESS TO SPECIALIZED OPHTHALMIC CARE IN RURAL AREAS

6.3 OPPORTUNITIES

6.3.1 RISE IN THE AGING POPULATION

6.3.2 RISE IN ONLINE RETAIL AND E-HEALTH PLATFORMS

6.3.3 ENHANCED PATIENT EDUCATION

6.4 CHALLENGES

6.4.1 RISING COSTS OF OPHTHALMIC TREATMENTS

6.4.2 SHORTAGE OF EYE CARE PROFESSIONALS

7 EUROPE OPHTHALMOLOGY MARKETEUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS

7.1 OVERVIEW

7.2 DEVICE

7.2.1 SURGICAL DEVICE

7.2.1.1 CATARACT SURGICAL DEVICES

7.2.1.2 OPHTHALMIC VISCOELASTIC DEVICES

7.2.1.2.1 PHACOEMULSIFICATION DEVICES

7.2.1.2.2 CATARACT SURGICAL LASERS

7.2.1.2.3 IOL INJECTORS

7.2.1.3 VITREORETINAL SURGICAL DEVICES

7.2.1.3.1 VITREORETINAL PACKS

7.2.1.3.2 VITRECTOMY MACHINES

7.2.1.3.3 VITRECTOMY PROBES

7.2.1.3.4 PHOTOCOAGULATION LASERS

7.2.1.3.5 ILLUMINATION DEVICES

7.2.1.4 REFRACTIVE SURGICAL DEVICES

7.2.1.4.1 FEMTOSECOND LASERS

7.2.1.4.2 EXCIMER LASERS

7.2.1.4.3 OTHER REFRACTIVE SURGICAL LASERS

7.2.1.5 GLAUCOMA SURGICAL DEVICES

7.2.1.5.1 GLAUCOMA DRAINAGE DEVICES

7.2.1.5.2 GLAUCOMA LASER SYSTEMS

7.2.1.5.3 MICRO INVASIVE GLAUCOMA SURGERY DEVICES

7.2.2 DIAGNOSTIC DEVICE

7.2.2.1 OPTICAL COHERENCE TOMOGRAPHY (OCT) SCANNERS

7.2.2.2 AUTOREFRACTORS & KERATOMETERS

7.2.2.3 TONOMETERS

7.2.2.4 PHOROPTERS

7.2.2.5 RETINOSCOPES

7.2.2.6 OPHTHALMOSCOPES

7.2.2.7 SLIT LAMPS

7.2.2.8 PERIMETERS/VISUAL FIELD ANALYZERS

7.2.2.9 CORNEAL TOPOGRAPHY SYSTEMS

7.2.2.10 FUNDUS CAMERAS

7.2.2.11 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS

7.2.2.11.1 A- SCAN IMAGING SYSTEM

7.2.2.11.2 B-SCAN IMAGING SYSTEM

7.2.2.11.3 PACHYMETERS

7.2.2.11.4 ULTRASOUND BIOMICROSCOPES

7.2.2.12 LENSMETERS

7.2.2.13 WAVEFRONT ABERROMETERS

7.2.2.14 OPTICAL BIOMETRY SYSTEMS

7.2.2.15 SPECULAR MICROSCOPES

7.2.2.16 CHART PROJECTORS

7.2.3 OPHTHALMIC SURGICAL ACCESSORIES

7.2.3.1 SURGICAL INSTRUMENTS & KITS

7.2.3.2 OPHTHALMIC FORCEPS

7.2.3.3 OPHTHALMIC SPATULA

7.2.3.4 OPHTHALMIC TIPS AND HANDLES

7.2.3.5 OPHTHALMIC CANNULAS

7.2.3.6 OPHTHALMIC SCISSORS

7.2.3.7 OTHERS SURGICAL ACCESSORIES

7.2.4 OPHTHALMIC MICROSCOPES

7.3 DRUGS

7.3.1 ANTI-VEGF DRUGS

7.3.1.1 RANIBIZUMAB

7.3.1.2 BEVACIZUMAB

7.3.2 ANTI-GLAUCOMA DRUGS

7.3.2.1 PROSTAGLANDIN ANALOGS

7.3.2.1.1 LATANOPROST

7.3.2.1.2 BIMATOPROST

7.3.2.1.3 TRAVOPROST

7.3.2.1.4 TAFLUPROST

7.3.2.1.5 LATANOPROSTENE

7.3.2.2 BETA ADRENERGIC ANTAGONISTS

7.3.2.2.1 TIMOLAL MALEATE

7.3.2.2.2 BETAXOLOL

7.3.2.3 ALPHA ADRENERGIC AGONISTS

7.3.2.3.1 EPINEPHRINE

7.3.2.3.2 DEPIVEPRINE

7.3.2.4 MIOTICS

7.3.2.4.1 PILOCARPINE

7.3.2.4.2 ESERINE

7.3.3 ANTI-INFLAMMATION DRUGS

7.3.3.1 STEROIDAL ANTI-INFLAMMATORY DRUGS

7.3.3.2 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

7.3.4 RETINAL DISORDER DRUGS

7.3.5 DRY EYE DRUGS

7.3.6 ALLERGIC CONJUCTIVITIS DRUGS

7.3.7 OTHERS

7.3.7.1 BRANDED

7.3.7.2 GENERIC

7.3.7.3 PRESCRIPTION

7.3.7.4 OVER THE COUNTER

7.3.7.5 TOPICAL

7.3.7.6 LOCAL OCULAR

7.3.7.7 INJECTABLES

7.3.7.8 ORAL

7.3.7.9 OTHERS

7.3.7.10 EYE DROPS

7.3.7.11 EYE SOLUTION

7.3.7.12 CREAM & OINTMENTS

7.3.7.13 GEL

7.3.7.14 OTHERS

7.3.7.15 INTRAVITREAL

7.3.7.16 SUBCONJUNCTIVAL

7.3.7.17 RETROBULBAR

7.3.7.18 INTRACAMERAL

7.3.7.19 INTRAMUSCULAR

7.3.7.20 INTRAVENOUS

7.3.7.21 OTHERS

7.3.7.22 TABLET

7.3.7.23 CAPSULES

7.3.7.24 OTHERS

7.4 OTHERS

7.4.1 VISION CARE PRODUCTS

7.4.1.1 SPECTACLES

7.4.1.2 CONTACT LENSES

7.4.1.2.1 SOFT CONTACT LENSES

7.4.1.2.2 HYBRID CONTACT LENSES

7.4.1.2.3 RIGID GAS PERMEABLE LENSES

7.4.2 OTHERS

8 EUROPE OPHTHALMOLOGY MARKET, BY DISEASES

8.1 OVERVIEW

8.2 CATARACT

8.3 REFRACTIVE DISORDERS

8.4 GLAUCOMA

8.5 AGE-RELATED MACULAR DEGENERATION

8.6 INFLAMMATORY DISEASES

8.7 OTHERS

9 EUROPE OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION

9.1 OVERVIEW

9.2 REFRACTION

9.2.1 AUTOMATED REFRACTOMETERS

9.2.2 SET OF TRIAL LENSES

9.2.3 CYCLOPLEGIC DRUGS

9.2.4 TRIAL FRAME

9.2.5 SELF-ILLUMINATED/ MIRROR RETINOSCOPE

9.2.6 JACKSON CROSS CYLINDER

9.3 VISUAL ACUITY TEST

9.3.1 SNELLEN'S CHART

9.3.2 NEAR VISION CHARTS

9.4 INTRAOCULAR PRESSURE

9.4.1 TONOMETERS (GOLDMANN, TONO-PEN, PERKINS, SHIOTZ)

9.4.2 OTHERS

9.5 ANTERIOR SEGMENT AND PUPILLARY EXAMINATION

9.5.1 SLIT LAMP BIOMICROSCOPE

9.5.2 TORCH LIGHT

9.6 VISUAL FIELDS TEST

9.6.1 CENTRAL 30-2 FULL THRESHOLD HUMPHREY VISUAL FIELD ANALYZER

9.6.2 FREQUENCY DOUBLING PERIMETER

9.6.3 GOLDMANN KINETIC PERIMETER

9.7 COLOR VISION TEST

9.8 OTHERS

10 EUROPE OPHTHALMOLOGY MARKET, BY END USER

10.1 OVERVIEW

10.2 CLINICS

10.3 HOSPITALS

10.4 HOME HEALTHCARE

10.5 OTHERS

11 EUROPE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 RETAIL SALES

11.2.1 RETAIL SHOPS

11.2.2 HOSPITAL PHARMACY

11.2.3 ONLINE PHARMACY

11.3 DIRECT TENDER

11.4 OTHERS

12 EUROPE OPHTHALMOLOGY MARKET BY GEOGRAPHY

12.1 EUROPE

12.1.1 GERMANY

12.1.2 FRANCE

12.1.3 U.K.

12.1.4 ITALY

12.1.5 SPAIN

12.1.6 SWITZERLAND

12.1.7 RUSSIA

12.1.8 BELGIUM

12.1.9 NETHERLANDS

12.1.10 TURKEY

12.1.11 REST OF EUROPE

13 EUROPE OPHTHALMOLOGY MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: EUROPE

14 SWOT ANALYSIS

15 COMPANY PROFILES

15.1 ALCON

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENT

15.2 JOHNSON & JOHNSON SERVICES, INC.

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENT

15.3 ESSILOR LUXOTTICA

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENT

15.4 NOVARTIS AG

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENT

15.5 BAUSCH + LOMB

15.5.1 COMPANY SNAPSHOT

15.5.2 COMPANY SHARE ANALYSIS

15.5.3 REVENUE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENT

15.6 ABBVIE INC.

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENT

15.7 BAYER AG

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 PRODUCT PORTFOLIO

15.7.4 RECENT DEVELOPMENT

15.8 CARL ZEISS MEDITEC AG

15.8.1 COMPANY SNAPSHOT

15.8.2 REVENUE ANALYSIS

15.8.3 PRODUCT PORTFOLIO

15.8.4 RECENT DEVELOPMENT

15.9 COOPER COMPANIES

15.9.1 COMPANY SNAPSHOT

15.9.2 REVENUE ANALYSIS

15.9.3 PRODUCT PORTFOLIO

15.1 DOMPÉ

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENT

15.11 F. HOFFMANN-LA ROCHE LTD

15.11.1 COMPANY SNAPSHOT

15.11.2 REVENUE ANALYSIS

15.11.3 PRODUCT PORTFOLIO

15.11.4 RECENT DEVELOPMENT

15.12 GLAUKOS CORPORATION

15.12.1 COMPANY SNAPSHOT

15.12.2 REVENUE ANALYSIS

15.12.3 PRODUCT PORTFOLIO

15.12.4 RECENT DEVELOPMENT

15.13 HAAG-STREIT

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENT

15.14 HOYA CORPORATION

15.14.1 COMPANY SNAPSHOT

15.14.2 REVENUE ANALYSIS

15.14.3 PRODUCT PORTFOLIO

15.14.4 RECENT DEVELOPMENT

15.15 LUMENIS BE LTD.

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 NIDEK CO.

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENT

15.17 REICHERT, INC

15.17.1 COMPANY SNAPSHOT

15.17.2 REVENUE ANALYSIS

15.17.3 PRODUCT PORTFOLIO

15.17.4 RECENT DEVELOPMENT

15.18 SANTEN PHARMACEUTICAL CO.

15.18.1 COMPANY SNAPSHOT

15.18.2 REVENUE ANALYSIS

15.18.3 PRODUCT PORTFOLIO

15.18.4 RECENT DEVELOPMENT

15.19 STAAR SURGICAL

15.19.1 COMPANY SNAPSHOT

15.19.2 REVENUE ANALYSIS

15.19.3 PRODUCT PORTFOLIO

15.19.4 RECENT DEVELOPMENT

15.2 TOPCON CORPORATION

15.20.1 COMPANY SNAPSHOT

15.20.2 REVENUE ANALYSIS

15.20.3 PRODUCT PORTFOLIO

15.20.4 RECENT DEVELOPMENT

15.21 ZIEMER OPHTHALMIC SYSTEMS AG

15.21.1 COMPANY SNAPSHOT

15.21.2 PRODUCT PORTFOLIO

15.21.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

Liste des tableaux

TABLE 1 EUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 2 EUROPE DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 3 EUROPE SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 4 EUROPE OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 5 EUROPE VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 6 EUROPE REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 7 EUROPE GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 8 EUROPE DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 9 EUROPE OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 10 EUROPE OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 11 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 12 EUROPE ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 13 EUROPE ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 14 EUROPE PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 15 EUROPE BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 16 EUROPE ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 17 EUROPE MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 18 EUROPE ANTI INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 19 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 20 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 21 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 22 EUROPE TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 23 EUROPE LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 24 EUROPE INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 25 EUROPE ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 26 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 27 EUROPE VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 28 EUROPE CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 29 EUROPE OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 30 EUROPE CATARACT IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 31 EUROPE REFRACTIVE DISORDERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 32 EUROPE GLAUCOMA IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 33 EUROPE AGE-RELATED MACULAR DEGENERATION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 34 EUROPE INFLAMMATORY DISEASES IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 35 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 36 EUROPE OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 37 EUROPE REFRACTION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 38 EUROPE REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 39 EUROPE VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 40 EUROPE VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 41 EUROPE INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 42 EUROPE INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 43 EUROPE ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 44 EUROPE ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 45 EUROPE VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 46 EUROPE VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 47 EUROPE COLOR VISION TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 48 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 49 EUROPE OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 50 EUROPE CLINICS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 51 EUROPE HOSPITALS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 52 EUROPE HOME HEALTHCARE IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 53 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 54 EUROPE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 55 EUROPE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 56 EUROPE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 57 EUROPE DIRECT TENDER IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 58 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 59 EUROPE OPHTHALMOLOGY MARKET, BY COUNTRY, 2018-2032 (USD MILLION)

TABLE 60 EUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 61 EUROPE DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 62 EUROPE SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 63 EUROPE OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 64 EUROPE VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 65 EUROPE REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 66 EUROPE GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 67 EUROPE DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 68 EUROPE OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 69 EUROPE OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 70 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 71 EUROPE ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 72 EUROPE ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 73 EUROPE PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 74 EUROPE BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 75 EUROPE ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 76 EUROPE MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 77 EUROPE ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 78 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 79 EUROPE VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 80 EUROPE CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 81 EUROPE OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 82 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 83 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 84 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 85 EUROPE TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 86 EUROPE LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 87 EUROPE INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 88 EUROPE ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 89 EUROPE OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 90 EUROPE REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 91 EUROPE VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 92 EUROPE INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 93 EUROPE ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 94 EUROPE VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 95 EUROPE OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 96 EUROPE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 97 EUROPE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 98 GERMANY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 99 GERMANY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 100 GERMANY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 101 GERMANY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 102 GERMANY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 103 GERMANY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 104 GERMANY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 105 GERMANY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 106 GERMANY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 107 GERMANY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 108 GERMANY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 109 GERMANY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 110 GERMANY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 111 GERMANY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 112 GERMANY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 113 GERMANY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 114 GERMANY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 115 GERMANY ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 116 GERMANY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 117 GERMANY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 118 GERMANY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 119 GERMANY OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 120 GERMANY DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 121 GERMANY DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 122 GERMANY DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 123 GERMANY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 124 GERMANY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 125 GERMANY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 126 GERMANY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 127 GERMANY OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 128 GERMANY REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 129 GERMANY VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 130 GERMANY INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 131 GERMANY ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 132 GERMANY VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 133 GERMANY OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 134 GERMANY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 135 GERMANY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 136 FRANCE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 137 FRANCE DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 138 FRANCE SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 139 FRANCE OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 140 FRANCE VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 141 FRANCE REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 142 FRANCE GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 143 FRANCE DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 144 FRANCE OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 145 FRANCE OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 146 FRANCE DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 147 FRANCE ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 148 FRANCE ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 149 FRANCE PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 150 FRANCE BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 151 FRANCE ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 152 FRANCE MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 153 FRANCE ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 154 FRANCE OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 155 FRANCE VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 156 FRANCE CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 157 FRANCE OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 158 FRANCE DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 159 FRANCE DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 160 FRANCE DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 161 FRANCE TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 162 FRANCE LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 163 FRANCE INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 164 FRANCE ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 165 FRANCE OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 166 FRANCE REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 167 FRANCE VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 168 FRANCE INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 169 FRANCE ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 170 FRANCE VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 171 FRANCE OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 172 FRANCE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 173 FRANCE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 174 U.K. OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 175 U.K. DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 176 U.K. SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 177 U.K. OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 178 U.K. VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 179 U.K. REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 180 U.K. GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 181 U.K. DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 182 U.K. OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 183 U.K. OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 184 U.K. DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 185 U.K. ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 186 U.K. ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 187 U.K. PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 188 U.K. BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 189 U.K. ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 190 U.K. MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 191 U.K. ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 192 U.K. OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 193 U.K. VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 194 U.K. CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 195 U.K. OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 196 U.K. DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 197 U.K. DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 198 U.K. DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 199 U.K. TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 200 U.K. LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 201 U.K. INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 202 U.K. ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 203 U.K. OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 204 U.K. REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 205 U.K. VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 206 U.K. INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 207 U.K. ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 208 U.K. VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 209 U.K. OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 210 U.K. OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 211 U.K. RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 212 ITALY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 213 ITALY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 214 ITALY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 215 ITALY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 216 ITALY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 217 ITALY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 218 ITALY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 219 ITALY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 220 ITALY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 221 ITALY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 222 ITALY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 223 ITALY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 224 ITALY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 225 ITALY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 226 ITALY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 227 ITALY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 228 ITALY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 229 ITALY ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 230 ITALY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 231 ITALY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 232 ITALY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 233 ITALY OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 234 ITALY DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 235 ITALY DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 236 ITALY DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 237 ITALY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 238 ITALY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 239 ITALY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 240 ITALY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 241 ITALY OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 242 ITALY REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 243 ITALY VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 244 ITALY INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 245 ITALY ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 246 ITALY VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 247 ITALY OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 248 ITALY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 249 ITALY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 250 SPAIN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 251 SPAIN DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 252 SPAIN SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 253 SPAIN OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 254 SPAIN VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 255 SPAIN REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 256 SPAIN GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 257 SPAIN DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 258 SPAIN OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 259 SPAIN OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 260 SPAIN DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 261 SPAIN ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 262 SPAIN ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 263 SPAIN PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 264 SPAIN BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 265 SPAIN ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 266 SPAIN MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 267 SPAIN ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 268 SPAIN OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 269 SPAIN VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 270 SPAIN CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 271 SPAIN OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 272 SPAIN DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 273 SPAIN DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 274 SPAIN DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 275 SPAIN TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 276 SPAIN LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 277 SPAIN INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 278 SPAIN ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 279 SPAIN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 280 SPAIN REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 281 SPAIN VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 282 SPAIN INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 283 SPAIN ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 284 SPAIN VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 285 SPAIN OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 286 SPAIN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 287 SPAIN RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 288 SWITZERLAND OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 289 SWITZERLAND DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 290 SWITZERLAND SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 291 SWITZERLAND OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 292 SWITZERLAND VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 293 SWITZERLAND REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 294 SWITZERLAND GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 295 SWITZERLAND DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 296 SWITZERLAND OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 297 SWITZERLAND OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 298 SWITZERLAND DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 299 SWITZERLAND ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 300 SWITZERLAND ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 301 SWITZERLAND PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 302 SWITZERLAND BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 303 SWITZERLAND ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 304 SWITZERLAND MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 305 SWITZERLAND ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 306 SWITZERLAND OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 307 SWITZERLAND VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 308 SWITZERLAND CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 309 SWITZERLAND OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 310 SWITZERLAND DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 311 SWITZERLAND DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 312 SWITZERLAND DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 313 SWITZERLAND TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 314 SWITZERLAND LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 315 SWITZERLAND INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 316 SWITZERLAND ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 317 SWITZERLAND OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 318 SWITZERLAND REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 319 SWITZERLAND VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 320 SWITZERLAND INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 321 SWITZERLAND ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 322 SWITZERLAND VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 323 SWITZERLAND OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 324 SWITZERLAND OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 325 SWITZERLAND RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 326 RUSSIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 327 RUSSIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 328 RUSSIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 329 RUSSIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 330 RUSSIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 331 RUSSIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 332 RUSSIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 333 RUSSIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 334 RUSSIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 335 RUSSIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 336 RUSSIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 337 RUSSIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 338 RUSSIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 339 RUSSIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 340 RUSSIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 341 RUSSIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 342 RUSSIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 343 RUSSIA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 344 RUSSIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 345 RUSSIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 346 RUSSIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 347 RUSSIA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 348 RUSSIA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 349 RUSSIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 350 RUSSIA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 351 RUSSIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 352 RUSSIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 353 RUSSIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 354 RUSSIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 355 RUSSIA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 356 RUSSIA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 357 RUSSIA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 358 RUSSIA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 359 RUSSIA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 360 RUSSIA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 361 RUSSIA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 362 RUSSIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 363 RUSSIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 364 BELGIUM OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 365 BELGIUM DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 366 BELGIUM SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 367 BELGIUM OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 368 BELGIUM VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 369 BELGIUM REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 370 BELGIUM GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 371 BELGIUM DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 372 BELGIUM OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 373 BELGIUM OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 374 BELGIUM DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 375 BELGIUM ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 376 BELGIUM ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 377 BELGIUM PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 378 BELGIUM BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 379 BELGIUM ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 380 BELGIUM MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 381 BELGIUM ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 382 BELGIUM OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 383 BELGIUM VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 384 BELGIUM CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 385 BELGIUM OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 386 BELGIUM DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 387 BELGIUM DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 388 BELGIUM DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 389 BELGIUM TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 390 BELGIUM LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 391 BELGIUM INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 392 BELGIUM ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 393 BELGIUM OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 394 BELGIUM REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 395 BELGIUM VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 396 BELGIUM INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 397 BELGIUM ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 398 BELGIUM VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 399 BELGIUM OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 400 BELGIUM OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 401 BELGIUM RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 402 NETHERLANDS OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 403 NETHERLANDS DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 404 NETHERLANDS SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 405 NETHERLANDS OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 406 NETHERLANDS VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 407 NETHERLANDS REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 408 NETHERLANDS GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 409 NETHERLANDS DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 410 NETHERLANDS OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 411 NETHERLANDS OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 412 NETHERLANDS DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 413 NETHERLANDS ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 414 NETHERLANDS ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 415 NETHERLANDS PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 416 NETHERLANDS BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 417 NETHERLANDS ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 418 NETHERLANDS MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 419 NETHERLANDS ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 420 NETHERLANDS OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 421 NETHERLANDS VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 422 NETHERLANDS CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 423 NETHERLANDS OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 424 NETHERLANDS DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 425 NETHERLANDS DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 426 NETHERLANDS DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 427 NETHERLANDS TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 428 NETHERLANDS LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 429 NETHERLANDS INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 430 NETHERLANDS ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 431 NETHERLANDS OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 432 NETHERLANDS REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 433 NETHERLANDS VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 434 NETHERLANDS INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 435 NETHERLANDS ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 436 NETHERLANDS VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 437 NETHERLANDS OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 438 NETHERLANDS OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 439 NETHERLANDS RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 440 TURKEY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 441 TURKEY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 442 TURKEY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 443 TURKEY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 444 TURKEY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 445 TURKEY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 446 TURKEY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 447 TURKEY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 448 TURKEY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 449 TURKEY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 450 TURKEY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 451 TURKEY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 452 TURKEY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 453 TURKEY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 454 TURKEY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 455 TURKEY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 456 TURKEY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 457 TURKEY ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 458 TURKEY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 459 TURKEY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 460 TURKEY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 461 TURKEY OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 462 TURKEY DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 463 TURKEY DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 464 TURKEY DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 465 TURKEY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 466 TURKEY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 467 TURKEY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 468 TURKEY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 469 TURKEY OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 470 TURKEY REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 471 TURKEY VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 472 TURKEY INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 473 TURKEY ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 474 TURKEY VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 475 TURKEY OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 476 TURKEY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 477 TURKEY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 478 REST OF EUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

Liste des figures

FIGURE 1 EUROPE OPHTHALMOLOGY MARKET: SEGMENTATION

FIGURE 2 EUROPE OPHTHALMOLOGY MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE OPHTHALMOLOGY MARKET: DROC ANALYSIS

FIGURE 4 EUROPE OPHTHALMOLOGY MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE OPHTHALMOLOGY MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE OPHTHALMOLOGY MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE OPHTHALMOLOGY MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 EUROPE OPHTHALMOLOGY MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE OPHTHALMOLOGY MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE OPHTHALMOLOGY MARKET: SEGMENTATION

FIGURE 11 THREE SEGMENTS COMPRISE THE EUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS

FIGURE 12 EXECUTIVE SUMMARY

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 RISING INCIDENCE OF EYE DISORDERS IS DRIVING THE GROWTH OF THE EUROPE OPHTHALMOLOGY MARKET FROM 2025 TO 2032

FIGURE 15 THE PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE OPHTHALMOLOGY MARKET IN 2025 AND 2032

FIGURE 16 DROC ANALYSIS

FIGURE 17 EUROPE OPHTHALMOLOGY MARKET: BY PRODUCTS, 2024

FIGURE 18 EUROPE OPHTHALMOLOGY MARKET: BY PRODUCTS, 2025-2032 (USD MILLION)

FIGURE 19 EUROPE OPHTHALMOLOGY MARKET: BY PRODUCTS, CAGR (2025-2032)

FIGURE 20 EUROPE OPHTHALMOLOGY MARKET: BY PRODUCTS, LIFELINE CURVE

FIGURE 21 EUROPE OPHTHALMOLOGY MARKET: BY DISEASES, 2024

FIGURE 22 EUROPE OPHTHALMOLOGY MARKET: BY DISEASES, 2025-2032 (USD MILLION)

FIGURE 23 EUROPE OPHTHALMOLOGY MARKET: BY DISEASES, CAGR (2025-2032)

FIGURE 24 EUROPE OPHTHALMOLOGY MARKET: BY DISEASES, LIFELINE CURVE

FIGURE 25 EUROPE OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, 2024

FIGURE 26 EUROPE OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, 2025-2032 (USD MILLION)

FIGURE 27 EUROPE OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, CAGR (2025-2032)

FIGURE 28 EUROPE OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, LIFELINE CURVE

FIGURE 29 EUROPE OPHTHALMOLOGY MARKET: BY END USER, 2024

FIGURE 30 EUROPE OPHTHALMOLOGY MARKET: BY END USER, 2025-2032 (USD MILLION)

FIGURE 31 EUROPE OPHTHALMOLOGY MARKET: BY END USER, CAGR (2025-2032)

FIGURE 32 EUROPE OPHTHALMOLOGY MARKET: BY END USER, LIFELINE CURVE

FIGURE 33 EUROPE OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL ,2024

FIGURE 34 EUROPE OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)

FIGURE 35 EUROPE OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)

FIGURE 36 EUROPE OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 37 EUROPE OPHTHALMOLOGY MARKET SNAPSHOT

FIGURE 38 EUROPE OPHTHALMOLOGY MARKET: COMPANY SHARE 2024 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

The major companies in the Europe ophthalmology market are Alcon, Regeneron Pharmaceuticals Inc., Johnson & Johnson, Inc., Reichert, Inc., Novartis AG, Bausch & Lomb Incorporated, HOYA Corporation., The Cooper Companies Inc., Santen Pharmaceutical Co., Ltd., etc.
Products, disease, prescription mode, drug type, route of administration, end-user, and distribution channel are the factors on which the Europe ophthalmology market research is based.
The rising prevalence of ophthalmic disorders & ocular pains & Rise in traumatic injuries are the growth drivers of the Europe ophthalmology market.

Parcourir les pages associées

Banner
Testimonial
Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future